Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 81.45

-1.6%

Dec 29 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2658)	9/8/2010 12:01:59 PM
From: Jibacoa	Read Replies (1) of 3722

MAPP is up 8.55% trading at its intraday H on volume about half its ADV bigcharts.marketwatch.com It announced some results on Levadex, its drug for migraine. To date, more than 400 patients have completed at least six months of treatment and more than 200 patients have completed twelve months of treatment. The drug has been well tolerated and no serious adverse events have been reported. MAPP expects to release complete results from this trial in the 4thQ and to submit an NDA in the first half of 2011.<g> The ACTAY is $21.33 That would be a good % gain from present levels.<g> MAPP has a good institutional following. The insiders hold around 20% It has around $2 in csh/shr but has been burning its cash at a good clip. I will place a TT at $14 pending further developments.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next